Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
1.138 Leser
Artikel bewerten:
(2)

Classworx: ClassWorx Announces Interview with DeltaVera with Founder Sam Andrus, Now Live on Youtube

Finanznachrichten News

ATLANTA, GA / ACCESSWIRE / May 28, 2021 / Classworx, Inc. formerly known as Chill N Out Cryotherapy Inc. (OTC PINK:CHNO) and owner of ClassWorx.com, a community for people offering Zoom events that can list their Zoom events in their profile that gets displayed on ClassWorx, has published the interview with Sam Andrus, founder of DeltaVera on Youtube.

The live Zoom interview was held on May 27, 2021 and lasted approximately 34 minutes. In the interview, Sam Andrus discusses DeltaVera and their Delta 8 Gummies 8 Pre Rolls along with the Delta 8 Market and how Delta 8 has its own set of advantages over Delta 9.

The interview is now available on the ClassWorx YouTube channel. Follow us on YouTube to watch future interviews.

Classworx offers interviews to company CEOs and Presidents who are interested in telling their stories to the public. To schedule an interview, please contact ClassWorx, Inc. at the contact information listed below.

ClassWorx, Inc. completed its name change with the state of Delaware from Chill N Out Cryotherapy, Inc. to Classworx, Inc. The company filed its name change with FINRA and is awaiting approval.

About DeltaVera
At DeltaVera we strongly believe that Delta 8 THC can offer a safe, enjoyable and healthy experience. Though Delta 8 THC has much in common with Delta 9 THC, it is considerably less psychoactive. It is also a shorter lived high. These advantages make Delta 8 perfect for those looking for a brief respite from a busy schedule, for athletes and adventurers who are looking to make the most of their recovery, and for the artist inside all of us looking for a new perspective.

?Our enthusiasm for Delta 8 THC inspired us to start DeltaVera with a mission to offer the best Delta 8 experience in the field. Our products are sourced from the very best hemp farms in the United States, and are strictly tested to ensure accurate and reliable results. They are then packaged in renewable and reusable containers, and are labeled with a QR code to ensure easy access to our test results.

?We offer the best edibles and smokables in the industry to ensure that every THC user has the opportunity to enjoy this easy-going cannabinoid in whichever way they desire. We strive to stay ahead of the curve to meet new, healthy and enjoyable innovations the moment they arrive. Please look through our site to view our products, to learn more about Delta 8 THC, or to find a carrier of DeltaVera products near you.

About Classworx, Inc. (formerly known as Chill N Out Cryotherapy, Inc.)
Chill N Out Cryotherapy, Inc. (OTC PINK:CHNO), a Delaware Corporation, owns and operates ClassWorx.com. Chill N Out Cryotherapy, Inc. currently trades on the OTC Pinks under the stock symbol CHNO. Classworx provides an internet-based, global network-directory of people offering Virtual classes or events utilizing video conferencing to remotely deliver individual or group instruction in a broad range of disciplines ("virtual classes"). The Company is based in the Atlanta, Georgia, area spans a global outreach through the worldwide web.

Safe Harbor:
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of Chill N Out Cryotherapy, Inc. DBA Classworx to differ materially from those implied or expressed.

Contact:
Raymond Firth
470-448-4734
www.classworx.com

SOURCE: ClassWorx



View source version on accesswire.com:
https://www.accesswire.com/649581/ClassWorx-Announces-Interview-with-DeltaVera-with-Founder-Sam-Andrus-Now-Live-on-Youtube

© 2021 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.